VVUS - バイバス (VIVUS Inc.) バイバス

 VVUSのチャート


 VVUSの企業情報

symbol VVUS
会社名 Vivus Inc (バイバス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 医薬品   医療関連(Health Care)
概要 事業概要 バイバス(VIVUS Inc.)はバイオ医薬品会社。同社は肥満、睡眠時無呼吸症候群、糖尿病、及び男性の性的健康など満たされていないニーズ向けの治療薬の開発・商業化に従事する。同社の薬物「Qsymia」(フェンテルミンとトピラメート徐放)は肥満の治療のために、高血圧、2型糖尿病または高コレステロール(脂質異常症)など少なくとも1つのウェイト関連併存疾患を有す、30とその以上(肥満)または27とその以上(過体重)の初期ボディマス指数(BMI)を持つ成人のの患者向けの慢性的な体重管理のための増加した身体活動及び低カロリー食の補助として、米国食品医薬品局(FDA)によって承認された。薬物「Qsymia」はフェンテルミンとトピラマートの2つの以前に承認された薬から、低用量の有効成分を組み込んでいる。同社は睡眠時無呼吸の治療のための「Qsymia」と2型糖尿病の治療のための「Qsymia」の第2相臨床試験を完了した。同社の薬物は「STENDRA」または「avanafil」を含む。   バイバスは米国のバイオ医薬品会社。肥満症、睡眠時無呼吸症、糖尿病、性機能障害の治療薬を開発、販売する。主要製品は、肥満症の治療薬「Qsymia」と、経口ホスホジエステラ―ゼタイプ5阻害薬「ステンドラ」、別名「アバナフィル」である。「アバナフィル」は、田辺三菱製薬株式会社からライセンスを受けた勃起不全の治療薬である。本社はカリフォルニア州。   VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.
本社所在地 900 E. Hamilton Avenue Suite 550 Campbell CA 95008 USA
代表者氏名 David York Norton デヴィッドヨークノートン
代表者役職名 Independent Chairman of the Board
電話番号 +1 650-934-5200
設立年月日 33329
市場名 NASDAQ National Market System
ipoyear 1994年
従業員数 52人
url www.vivus.com
nasdaq_url https://www.nasdaq.com/symbol/vvus
adr_tso
EBITDA EBITDA(百万ドル) -3.29300
終値(lastsale) 4.42
時価総額(marketcap) 4695242.24
時価総額 時価総額(百万ドル) 48.33336
売上高 売上高(百万ドル) 53.99400
企業価値(EV) 企業価値(EV)(百万ドル) 220.28936
当期純利益 当期純利益(百万ドル) -38.97300
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 VIVUS Inc. revenues decreased 30% to $26.9M. Net loss increased 61% to $23.2M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Total interest and other expense net increase of 5% to $17.6M (expense) Stock-based Compensation in SGA increase of 41% to $1.8M (expense).

 VVUSのテクニカル分析


 VVUSのニュース

   VIVUS Reports First Quarter 2020 Financial Results  2020/05/06 20:05:00 GlobeNewswire
Company to host conference call today at 4:30pm ET CAMPBELL, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a…
   VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt  2020/05/01 12:35:00 GlobeNewswire
CAMPBELL, Calif., May 01, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced an agreement…
   Vivus Shares Rally On Accelerated Telemedicine Launch  2020/03/31 15:23:02 Benzinga
Shares of biopharma company VIVUS, Inc. (NASDAQ: VVUS ) are skyrocketing following an announcement concerning launch plans for telemedicine services. The Campbell, California-based company said it has accelerated the launch of telemedicine and remote monitoring modules for the Vivus Health Platform, which will allow participating physicians use it to conduct virtual office visits, regardless of whether the patient is prescribed a Vivus product. Vivus said it expects to enroll about 150-200 physicians in the new … Full story available on Benzinga.com
   The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies  2020/03/04 12:37:10 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 3) Acceleron Pharma Inc (NASDAQ: XLRN ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Fate Therapeutics Inc (NASDAQ: FATE ) (reacted to its fourth-quarter results) Forty Seven Inc (NASDAQ: FTSV ) IGM Biosciences Inc (NASDAQ: IGMS ) Inovio Pharmaceuticals Inc (NASDAQ: INO )( announced an accelerated timeline for COVID-19 vaccine development) Repro-Med Systems, Inc. (NASDAQ: KRMD ) SpringWorks Therapeutics Inc (NASDAQ: SWTX ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 3) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) Akorn, Inc. (NASDAQ: AKRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) ANI Pharmaceuticals Inc (NASDAQ: ANIP ) Evolus Inc (NASDAQ: EOLS ) EXACT Sciences Corporation (NASDAQ: EXAS ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Midatech Pharma PLC-ADR (NASDAQ: MTP )(began trading on a reverse split adjusted basis) Mylan NV (NASDAQ: MYL ) Neuronetics Inc (NASDAQ: STIM )(announced its fourth-quarter results) Passage Bio Inc (NASDAQ: PASG )(IPOed last week) STRATA Skin Sciences Inc (NASDAQ: SSKN ) SurModics, Inc. (NASDAQ: SRDX ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) TransMedics Group Inc (NASDAQ: TMDX )(reported its fourth-quarter results) VIVUS, Inc. (NASDAQ: VVUS ) Xeris Pharmaceuticals Inc (NASDAQ: XERS ) See Also: Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates Stocks In Focus Takeda To Develop COVID-19 Treatments Takeda Pharmaceutical Co Ltd (NYSE: TAK ) said it is initiating the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin to treat high-risk individuals with the viral infection.
   The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy  2020/02/27 12:35:07 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 26.) Co-Diagnostics Inc (NASDAQ: CODX ) Fate Therapeutics Inc (NASDAQ: FATE ) Gilead Sciences, Inc. (NASDAQ: GILD ) Inspire Medical Systems Inc (NYSE: INSP ) (reacted to fourth-quarter results) Mersana Therapeutics Inc (NASDAQ: MRSN ) Moderna Inc (NASDAQ: MRNA ) Nevro Corp (NYSE: NVRO ) (announced fourth-quarter results) Oyster Point Pharma Inc (NASDAQ: OYST ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Revolution Medicines Inc (NASDAQ: RVMD ) Vir Biotechnology Inc (NASDAQ: VIR ) (announced a collaboration with WuXi Biologics for the development of antibodies to treat COVID-19) Down In The Dumps (Biotech stocks that hit 52-week lows Feb. 26.) ABIOMED, Inc. (NASDAQ: ABMD ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Acorda Therapeutics Inc (NASDAQ: ACOR ) AngioDynamics, Inc. (NASDAQ: ANGO ) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) Aptevo Therapeutics Inc (NASDAQ: APVO ) Auris Medical Holding Ltd (NASDAQ: EARS )(announced publication of results of a study showing anti-epileptic and anti-convulsive activity of betahistine in a mouse model) Blueprint Medicines Corp (NASDAQ: BPMC ) Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX ) Curis, Inc. (NASDAQ: CRIS ) Enochian Biosciences Inc (NASDAQ: ENOB ) Galectin Therapeutics Inc.
   VIVUS Reports First Quarter 2020 Financial Results  2020/05/06 20:05:00 GlobeNewswire
Company to host conference call today at 4:30pm ET CAMPBELL, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a…
   VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt  2020/05/01 12:35:00 GlobeNewswire
CAMPBELL, Calif., May 01, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced an agreement…
   Vivus Shares Rally On Accelerated Telemedicine Launch  2020/03/31 15:23:02 Benzinga
Shares of biopharma company VIVUS, Inc. (NASDAQ: VVUS ) are skyrocketing following an announcement concerning launch plans for telemedicine services. The Campbell, California-based company said it has accelerated the launch of telemedicine and remote monitoring modules for the Vivus Health Platform, which will allow participating physicians use it to conduct virtual office visits, regardless of whether the patient is prescribed a Vivus product. Vivus said it expects to enroll about 150-200 physicians in the new … Full story available on Benzinga.com
   The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies  2020/03/04 12:37:10 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 3) Acceleron Pharma Inc (NASDAQ: XLRN ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Fate Therapeutics Inc (NASDAQ: FATE ) (reacted to its fourth-quarter results) Forty Seven Inc (NASDAQ: FTSV ) IGM Biosciences Inc (NASDAQ: IGMS ) Inovio Pharmaceuticals Inc (NASDAQ: INO )( announced an accelerated timeline for COVID-19 vaccine development) Repro-Med Systems, Inc. (NASDAQ: KRMD ) SpringWorks Therapeutics Inc (NASDAQ: SWTX ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 3) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) Akorn, Inc. (NASDAQ: AKRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) ANI Pharmaceuticals Inc (NASDAQ: ANIP ) Evolus Inc (NASDAQ: EOLS ) EXACT Sciences Corporation (NASDAQ: EXAS ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Midatech Pharma PLC-ADR (NASDAQ: MTP )(began trading on a reverse split adjusted basis) Mylan NV (NASDAQ: MYL ) Neuronetics Inc (NASDAQ: STIM )(announced its fourth-quarter results) Passage Bio Inc (NASDAQ: PASG )(IPOed last week) STRATA Skin Sciences Inc (NASDAQ: SSKN ) SurModics, Inc. (NASDAQ: SRDX ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) TransMedics Group Inc (NASDAQ: TMDX )(reported its fourth-quarter results) VIVUS, Inc. (NASDAQ: VVUS ) Xeris Pharmaceuticals Inc (NASDAQ: XERS ) See Also: Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates Stocks In Focus Takeda To Develop COVID-19 Treatments Takeda Pharmaceutical Co Ltd (NYSE: TAK ) said it is initiating the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin to treat high-risk individuals with the viral infection.
   The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy  2020/02/27 12:35:07 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 26.) Co-Diagnostics Inc (NASDAQ: CODX ) Fate Therapeutics Inc (NASDAQ: FATE ) Gilead Sciences, Inc. (NASDAQ: GILD ) Inspire Medical Systems Inc (NYSE: INSP ) (reacted to fourth-quarter results) Mersana Therapeutics Inc (NASDAQ: MRSN ) Moderna Inc (NASDAQ: MRNA ) Nevro Corp (NYSE: NVRO ) (announced fourth-quarter results) Oyster Point Pharma Inc (NASDAQ: OYST ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Revolution Medicines Inc (NASDAQ: RVMD ) Vir Biotechnology Inc (NASDAQ: VIR ) (announced a collaboration with WuXi Biologics for the development of antibodies to treat COVID-19) Down In The Dumps (Biotech stocks that hit 52-week lows Feb. 26.) ABIOMED, Inc. (NASDAQ: ABMD ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Acorda Therapeutics Inc (NASDAQ: ACOR ) AngioDynamics, Inc. (NASDAQ: ANGO ) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) Aptevo Therapeutics Inc (NASDAQ: APVO ) Auris Medical Holding Ltd (NASDAQ: EARS )(announced publication of results of a study showing anti-epileptic and anti-convulsive activity of betahistine in a mouse model) Blueprint Medicines Corp (NASDAQ: BPMC ) Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX ) Curis, Inc. (NASDAQ: CRIS ) Enochian Biosciences Inc (NASDAQ: ENOB ) Galectin Therapeutics Inc.
   The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies  2020/03/04 12:37:10 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 3) Acceleron Pharma Inc (NASDAQ: XLRN ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Fate Therapeutics Inc (NASDAQ: FATE ) (reacted to its fourth-quarter results) Forty Seven Inc (NASDAQ: FTSV ) IGM Biosciences Inc (NASDAQ: IGMS ) Inovio Pharmaceuticals Inc (NASDAQ: INO )( announced an accelerated timeline for COVID-19 vaccine development) Repro-Med Systems, Inc. (NASDAQ: KRMD ) SpringWorks Therapeutics Inc (NASDAQ: SWTX ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 3) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) Akorn, Inc. (NASDAQ: AKRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) ANI Pharmaceuticals Inc (NASDAQ: ANIP ) Evolus Inc (NASDAQ: EOLS ) EXACT Sciences Corporation (NASDAQ: EXAS ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Midatech Pharma PLC-ADR (NASDAQ: MTP )(began trading on a reverse split adjusted basis) Mylan NV (NASDAQ: MYL ) Neuronetics Inc (NASDAQ: STIM )(announced its fourth-quarter results) Passage Bio Inc (NASDAQ: PASG )(IPOed last week) STRATA Skin Sciences Inc (NASDAQ: SSKN ) SurModics, Inc. (NASDAQ: SRDX ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) TransMedics Group Inc (NASDAQ: TMDX )(reported its fourth-quarter results) VIVUS, Inc. (NASDAQ: VVUS ) Xeris Pharmaceuticals Inc (NASDAQ: XERS ) See Also: Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates Stocks In Focus Takeda To Develop COVID-19 Treatments Takeda Pharmaceutical Co Ltd (NYSE: TAK ) said it is initiating the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin to treat high-risk individuals with the viral infection.
   The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy  2020/02/27 12:35:07 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 26.) Co-Diagnostics Inc (NASDAQ: CODX ) Fate Therapeutics Inc (NASDAQ: FATE ) Gilead Sciences, Inc. (NASDAQ: GILD ) Inspire Medical Systems Inc (NYSE: INSP ) (reacted to fourth-quarter results) Mersana Therapeutics Inc (NASDAQ: MRSN ) Moderna Inc (NASDAQ: MRNA ) Nevro Corp (NYSE: NVRO ) (announced fourth-quarter results) Oyster Point Pharma Inc (NASDAQ: OYST ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Revolution Medicines Inc (NASDAQ: RVMD ) Vir Biotechnology Inc (NASDAQ: VIR ) (announced a collaboration with WuXi Biologics for the development of antibodies to treat COVID-19) Down In The Dumps (Biotech stocks that hit 52-week lows Feb. 26.) ABIOMED, Inc. (NASDAQ: ABMD ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Acorda Therapeutics Inc (NASDAQ: ACOR ) AngioDynamics, Inc. (NASDAQ: ANGO ) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) Aptevo Therapeutics Inc (NASDAQ: APVO ) Auris Medical Holding Ltd (NASDAQ: EARS )(announced publication of results of a study showing anti-epileptic and anti-convulsive activity of betahistine in a mouse model) Blueprint Medicines Corp (NASDAQ: BPMC ) Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX ) Curis, Inc. (NASDAQ: CRIS ) Enochian Biosciences Inc (NASDAQ: ENOB ) Galectin Therapeutics Inc.
   The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance  2020/01/30 14:26:49 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 29) 10X Genomics Inc (NASDAQ: TXG ) Agile Therapeutics Inc (NASDAQ: AGRX ) Aptose Biosciences Inc (NASDAQ: APTO ) Catalent Inc (NYSE: CTLT ) Cabaletta Bio Inc (NASDAQ: CABA )(announced grant of orphan drug designation for its DSG3-CAART for the treatment of pemphigus vulgaris) AtriCure Inc. (NASDAQ: ATRC ) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Fate Therapeutics Inc (NASDAQ: FATE ) Hologic, Inc. (NASDAQ: HOLX ) Insulet Corporation (NASDAQ: PODD ) Johnson & Johnson (NYSE: JNJ )(confirmed it is working on treatment/vaccines for coronavirus) Nevro Corp (NYSE: NVRO ) Profound Medical Corp (NASDAQ: PROF ) Quest Diagnostics Inc (NYSE: DGX ) ResMed Inc. (NYSE: RMD ) Satsuma Pharmaceuticals Inc (NASDAQ: STSA )(reacted to publication of positive data readout for its lead drug candidate) Tandem Diabetes Care Inc (NASDAQ: TNDM ) West Pharmaceutical Services Inc. (NYSE: WST ) Zimmer Biomet Holdings Inc (NYSE: ZBH ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Jan. 29) Avanos Medical Inc (NYSE: AVNS ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) Endologix, Inc. (NASDAQ: ELGX ) Galectin Therapeutics Inc.
   The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut  2020/01/29 13:30:46 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 28) 10X Genomics Inc (NASDAQ: TXG ) Acceleron Pharma Inc (NASDAQ: XLRN ) ( announced positive Phase 2 results for its pulmonary hypertension drug) Agile Therapeutics Inc (NASDAQ: AGRX ) AtriCure Inc. (NASDAQ: ATRC ) Avenue Therapeutics Inc (NASDAQ: ATXI ) Catalent Inc (NYSE: CTLT ) Hologic, Inc. (NASDAQ: HOLX ) Insulet Corporation (NASDAQ: PODD ) Johnson & Johnson (NYSE: JNJ ) NeoGenomics, Inc. (NASDAQ: NEO ) Nevro Corp (NYSE: NVRO ) Profound Medical Corp (NASDAQ: PROF ) Quest Diagnostics Inc (NYSE: DGX ) Rapt Therapeutics Inc (NASDAQ: RAPT ) Satsuma Pharmaceuticals Inc (NASDAQ: STSA ) SI-Bone Inc (NASDAQ: SIBN ) TFF Pharmaceuticals Inc (NASDAQ: TFFP ) Y-mAbs Therapeutics, Inc (NASDAQ: YMAB )(H.C. Wainwright reiterated a Buy rating on shares) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Jan. 28) Correvio Pharma Corp (NASDAQ: CORV ) Endologix, Inc. (NASDAQ: ELGX ) Galectin Therapeutics Inc. (NASDAQ: GALT ) Heat Biologics Inc (NASDAQ: HTBX ) Neuronetics Inc (NASDAQ: STIM ) REDHILL BIOPHAR/S ADR (NASDAQ: RDHL ) Salarius Pharmaceuticals Inc (NASDAQ: SLRX ) X4 Pharmaceuticals Inc (NASDAQ: XFOR ) VIVUS, Inc. (NASDAQ: VVUS ) Stocks In Focus Novartis Q4 Sales, Core Income Rise, Guides to Sales, Earnings Growth Novartis AG (NYSE: NVS ) said its fourth-quarter sales rose 8% to $12.403 million, up 8% year-over-year.
   Un juzgado condena a Vivus por aplicar intereses de hasta el 2,333 %  2019/12/06 09:29:00 Investing.com
https://es.investing.com/news/economic-indicators/un-juzgado-condena-a-vivus-por-aplicar-intereses-de-hasta-el-2333--1946780

 関連キーワード  (医薬品 米国株 バイバス VVUS VIVUS Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)